Company Filing History:
Years Active: 2020
Title: The Innovative Contributions of Manny Bacolod
Introduction
Manny Bacolod is a notable inventor based in Richmond, VA, who has made significant contributions to the field of cancer research. His work focuses on understanding the genetic factors that influence cancer prognosis and treatment outcomes. With a keen interest in methylation processes, Bacolod has developed methods that can aid in the stratification of cancer patients based on their genetic profiles.
Latest Patents
Manny Bacolod holds a patent for his invention titled "Methylation site regulating expression of mda-9/syntenin." This patent outlines methods for prognosing the outcome of cancer and/or cancer treatment. The methods involve quantifying the level of methylation at a specific site that regulates the expression of the mda-9/Syntenin gene, specifically site cg17197774. High levels of methylation indicate a favorable prognosis, while low levels suggest a poor prognosis. This innovative approach allows for better risk stratification of patients with cancer.
Career Highlights
Bacolod is affiliated with Virginia Commonwealth University, where he conducts research and collaborates with other experts in the field. His work has garnered attention for its potential to improve cancer treatment strategies and patient outcomes.
Collaborations
Manny Bacolod collaborates with Paul B Fisher, a fellow researcher, to further explore the implications of methylation in cancer prognosis. Their combined expertise enhances the understanding of cancer biology and treatment.
Conclusion
Manny Bacolod's innovative work in cancer research exemplifies the importance of genetic factors in prognosis and treatment. His contributions through patented methods provide valuable insights that can lead to improved patient care and outcomes.